BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C. Retroperitoneal Fibrosis: Evolving Concepts. Rheumatic Disease Clinics of North America 2007;33:803-17. [DOI: 10.1016/j.rdc.2007.07.013] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Hajsadeghi S, Pakbaz M, Sadeghipour A, Ahari AA, Marzban M. A Case of IgG4-Related Constrictive Pericarditis With Literature Review. J Clin Rheumatol 2021;27:S331-4. [PMID: 35073632 DOI: 10.1097/RHU.0000000000001711] [Reference Citation Analysis]
2 Jacobs I, Ceulemans M, Wauters L, Breynaert C, Vermeire S, Verstockt B, Vanuytsel T. Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? Front Immunol 2021;12:754413. [PMID: 34737752 DOI: 10.3389/fimmu.2021.754413] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
3 Johnson WR, Hawkins AT. Large Bowel Obstruction. Clin Colon Rectal Surg 2021;34:233-41. [PMID: 34305472 DOI: 10.1055/s-0041-1729927] [Reference Citation Analysis]
4 Liu Y, Zhu L, Wang Z, Zeng Q, Yang F, Gao J, Wang Z, Wang K, Ren L, Zhang Y, Zhang S, Wang Y, Shen D, Xia C, Yu G, Li Z. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study. Rheumatology (Oxford) 2021;60:767-72. [PMID: 32793960 DOI: 10.1093/rheumatology/keaa411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Raglianti V, Rossi GM, Vaglio A. Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrol Dial Transplant 2020:gfaa083. [PMID: 33005943 DOI: 10.1093/ndt/gfaa083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
6 Chetrit M, Khan MA, Kapadia S. State of the Art Management of Aortic Valve Disease in Ankylosing Spondylitis. Curr Rheumatol Rep 2020;22:23. [PMID: 32410005 DOI: 10.1007/s11926-020-00898-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cervera-Bonilla S, Garcia Mora M, Rodriguez Ossa P, Messa O, Mendoza Díaz S. Medical Challenge Posed by Retroperitoneal Fibrosis: Case Reports and Literature Review. Cureus 2020;12:e6624. [PMID: 32064203 DOI: 10.7759/cureus.6624] [Reference Citation Analysis]
8 Argollo M, Gilardi D, Roda G, Fiorino G, Peyrin-biroulet L, Danese S. Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time? CPD 2019;25:47-56. [DOI: 10.2174/1381612825666190308100844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Vashi B, Khosroshahi A. IgG4-Related Disease with Emphasis on Its Gastrointestinal Manifestation. Gastroenterol Clin North Am. 2019;48:291-305. [PMID: 31046976 DOI: 10.1016/j.gtc.2019.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
10 Choi YK, Yang JH, Ahn SY, Ko GJ, Oh SW, Kim MG, Cho WY, Jo SK. Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease. Kidney Res Clin Pract 2019;38:42-8. [PMID: 30754935 DOI: 10.23876/j.krcp.18.0052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Yun SM, Kim SH, Kim EH. The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review. Front Pharmacol 2019;10:162. [PMID: 30873033 DOI: 10.3389/fphar.2019.00162] [Cited by in Crossref: 22] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
12 Palmisano A, Maritati F, Vaglio A. Chronic Periaortitis: an Update. Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0789-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yamakawa H, Sekine A, Yamanaka Y, Sadoyama S, Baba T, Hagiwara E, Okudela K, Ogura T. Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis. Intern Med 2017;56:1867-71. [PMID: 28717084 DOI: 10.2169/internalmedicine.56.7996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Chen SJ, Qin L, Xie YJ, Zhu JP, Zhang Q, Chen M. Ultrasonography for Preoperative Diagnosis of Retroperitoneal Fibrosis. Ultrasound Q 2017;33:162-6. [PMID: 28538448 DOI: 10.1097/RUQ.0000000000000293] [Reference Citation Analysis]
15 Jakhlal N, Elghazoui A, Jabbour Y, Karmouni T, Elkhader K, Koutani A, Ibenattya A. Fibrose rétropéritonéale: revue de littérature. Can Urol Assoc J 2017;11:E26-31. [PMID: 28163809 DOI: 10.5489/cuaj.4122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Maritati F, Iannuzzella F, Pavia MP, Pasquali S, Vaglio A. Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 2016;29:495-505. [PMID: 27098921 DOI: 10.1007/s40620-016-0303-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
17 Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. Eur J Intern Med. 2016;27:1-9. [PMID: 26481243 DOI: 10.1016/j.ejim.2015.09.022] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
18 Zhou HJ, Yan Y, Zhou B, Lan TF, Wang XY, Li CS. Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period. Chin Med J (Engl) 2015;128:804-10. [PMID: 25758277 DOI: 10.4103/0366-6999.152648] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
19 Mishra K, Zargar H, Tarplin S, Ramanathan R, Stein RJ. Idiopathic retroperitoneal fibrosis. J Urol. 2015;193:1657-1658. [PMID: 25659660 DOI: 10.1016/j.juro.2015.01.101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Med Interne. 2015;36:15-21. [PMID: 25455951 DOI: 10.1016/j.revmed.2014.10.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
21 Tzou M, Gazeley DJ, Mason PJ. Retroperitoneal fibrosis. Vasc Med 2014;19:407-14. [PMID: 25161213 DOI: 10.1177/1358863X14546160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
22 Liu H, Zhang G, Niu Y, Jiang N, Xiao W. Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature. Rheumatol Int 2014;34:1665-70. [DOI: 10.1007/s00296-014-3002-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
23 Yang JH, Cho HJ, Kim JR, Kim HW, Yun HH. Idiopathic retroperitoneal fibrosis mimicking periprosthetic hip infection. J Orthop Sci 2015;20:789-94. [PMID: 24504985 DOI: 10.1007/s00776-014-0532-4] [Reference Citation Analysis]
24 Bellamy MA, Tomich EB. Retroperitoneal fibrosis. CJEM 2014;16:63-4. [PMID: 24424002 DOI: 10.2310/8000.2013.131009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
25 Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP, Deshpande V. Rethinking Ormond’s disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore). 2013;92:82-91. [PMID: 23429355 DOI: 10.1097/md.0b013e318289610f] [Cited by in Crossref: 131] [Cited by in F6Publishing: 106] [Article Influence: 14.6] [Reference Citation Analysis]
26 Pipitone N, Vaglio A, Salvarani C. Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol 2012;26:439-48. [PMID: 23040359 DOI: 10.1016/j.berh.2012.07.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
27 Fernández-codina A, Martínez-valle F, Castro-marrero J, Detorres I, Vilardell-tarrés M, Ordi-ros J. Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol 2013;32:889-93. [DOI: 10.1007/s10067-013-2225-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
28 Mangieri D, Corradi D, Martorana D, Malerba G, Palmisano A, Libri I, Bartoli V, Carnevali ML, Goldoni M, Govoni P, Alinovi R, Buzio C, Vaglio A. Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant 2012;27:3875-84. [PMID: 23114905 DOI: 10.1093/ndt/gfs408] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
29 Dicke C, Kertész A, Henke RP, Hasenkamp J, Jung W, Trümper L, Wulf GG. Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT. Bone Marrow Transplant 2013;48:467-8. [PMID: 22964591 DOI: 10.1038/bmt.2012.165] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Hermet M, Kémény J, Guettrot-imbert G, Delèvaux I, Aumaître O, André M. Maladie fibrosclérosante à IgG4. La Presse Médicale 2012;41:682-94. [DOI: 10.1016/j.lpm.2011.10.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
31 Kollert F, Binder M, Probst C, Uhl M, Zirlik A, Kayser G, Voll RE, Peter HH, Zissel G, Prasse A, Warnatz K. CCL18 -- potential biomarker of fibroinflammatory activity in chronic periaortitis. J Rheumatol 2012;39:1407-12. [PMID: 22589264 DOI: 10.3899/jrheum.111143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
32 Clevenger JA, Wang M, MacLennan GT, Montironi R, Lopez-Beltran A, Cheng L. Evidence for clonal fibroblast proliferation and autoimmune process in idiopathic retroperitoneal fibrosis. Hum Pathol 2012;43:1875-80. [PMID: 22561019 DOI: 10.1016/j.humpath.2012.01.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
33 Sampert C, Lowichik A, Rollins M, Inman CJ, Bohnsack J, Pohl JF. Sclerosing mesenteritis in a child with celiac disease. J Pediatr Gastroenterol Nutr. 2011;53:688-690. [PMID: 21572343 DOI: 10.1097/mpg.0b013e3182238113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
34 Mehta A, Blodgett TM. Retroperitoneal fibrosis as a cause of positive FDG PET/CT. J Radiol Case Rep 2011;5:35-41. [PMID: 22470805 DOI: 10.3941/jrcr.v5i7.722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
35 Salvarani C, Calamia KT, Matteson EL, Hunder GG, Pipitone N, Miller DV, Warrington KJ. Vasculitis of the Gastrointestinal Tract in Chronic Periaortitis. Medicine 2011;90:28-39. [DOI: 10.1097/md.0b013e318207231e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
36 Palazzi C, Salvarani C, D'Angelo S, Olivieri I. Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine 2011;78:451-5. [PMID: 21185758 DOI: 10.1016/j.jbspin.2010.11.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
37 Li KP, Zhu J, Zhang JL, Huang F. Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol. 2011;30:601-605. [PMID: 20957401 DOI: 10.1007/s10067-010-1580-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
38 Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, Namiki M, Kasashima S, Kawashima A, Matsumoto Y. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33:1833-1839. [PMID: 19950407 DOI: 10.1097/pas.0b013e3181b72882] [Cited by in Crossref: 200] [Cited by in F6Publishing: 171] [Article Influence: 15.4] [Reference Citation Analysis]
39 Pipitone N, Salvarani C, Peter H. Chronische Periaortitis. Internist 2010;51:45-52. [DOI: 10.1007/s00108-009-2407-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
40 De Filippo M, Ingegnoli A, Carloni A, Verardo E, Sverzellati N, Onniboni M, Corsi A, Tomassetti S, Mazzei M, Volterrani L, Poletti V, Zompatori M. Erdheim-Chester disease: clinical and radiological findings. Radiol Med 2009;114:1319-29. [PMID: 19915998 DOI: 10.1007/s11547-009-0473-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
41 Vaglio A. Retroperitoneal Fibrosis: New Insights Into Clinical Presentation and Diagnosis. Medicine 2009;88:208-10. [DOI: 10.1097/md.0b013e3181afc4d1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
42 Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Practice & Research Clinical Rheumatology 2009;23:339-53. [DOI: 10.1016/j.berh.2008.12.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
43 Magrey MN, Husni ME, Kushner I, Calabrese LH. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 2009;61:674-9. [DOI: 10.1002/art.24461] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]